Vardhman Hold. (VHL)
Asset PlayFairStock Score: 25/100 — RISKY
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3,439 |
| Market Cap | ₹1,097.57 Cr |
| P/E Ratio | 4.36 |
| ROCE | 7.98% |
| ROE | 4.02% |
| Dividend Yield | 0.16% |
| Profit Growth | -18.3% |
| Debt/Equity | — |
| Sales Growth | -11.4% |
| Promoter Holding | 74.9% |
| 52-Week Range | ₹2,870 — ₹4,275 |
| Sector | Finance |
| Book Value | ₹11,796.37 |
Strengths
- Stock trades at ₹3,313.60 versus book value of ₹3,265.31, effectively at a P/B of 1.01, providing asset-backed downside support.
- Trailing P/E of 4.58 looks inexpensive on reported earnings.
- Promoter holding of 74.90% aligns controlling interests with long-term shareholders.
- Latest quarter net profit of ₹54 Cr shows the investment portfolio can generate meaningful earnings despite negligible sales.
Concerns
- ROE of only 4.02% means book value is growing slowly and capital is not being deployed productively.
- Sales declined 12.33% and profit declined 18.32%, while the Piotroski F-score of 3/9 points to deteriorating fundamentals.
- Dividend yield of just 0.15% means minority shareholders receive almost no cash return.
- FairStock Score of 25/100 and the wide 52-week range of ₹2,870.00–₹4,275.00 indicate significant risk at the current price.
AI Analysis
As a value investor, I first ask what I am buying. Vardhman Holdings is not a typical operating company—it is an investment vehicle. The financials tell me that immediately: quarterly sales of just ₹6 Cr against a net profit of ₹54 Cr. That gap means earnings are coming from investments, not from selling goods or services. So my analysis must focus on the assets behind the shares. At ₹3,313.60, the stock sits almost exactly at book value of ₹3,265.31, a P/B of 1.01. Ben Graham would not get excited about paying full rupee for net asset value; he would want a margin of safety. The low P/E of 4.58 looks tempting, but this can be an earnings trap if the underlying portfolio is stagnant. ROE is only 4.02% and ROCE 7.98%; the company is earning a thin return on its capital. Sales fell 12.33%, profit fell 18.32%, and the Piotroski F-score of 3/9 signals weak financial health. The dividend yield of 0.15% offers almost no income. With 74.90% promoter holding, minority shareholders are along for the ride, though the high stake does align interests. Ultimately, this is an asset play where the price is close to stated book value. I see no margin of safety. The market is not giving me a discount, and the return on equity does not justify paying up. I would wait for a larger discount to net asset value and evidence that the portfolio can generate better returns.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer